ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,069Medicare Part D Prescriptions Filled, Including Refills

Rank: 238 out of 1000

$493K Total Retail Price of All Prescriptions

Rank: 261 out of 1000

347 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 347 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 8,658 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 502 400 1 2
LISINOPRIL 460 366 2 5
SIMVASTATIN 440 355 3 3
AMLODIPINE BESYLATE 324 275 4 6
LEVOTHYROXINE SODIUM 290 260 5 4
PRAVASTATIN SODIUM 279 199 6 12
FUROSEMIDE 275 250 7 7
CITALOPRAM HBR 249 164 8 17
HYDROCODONE-ACETAMINOPHEN 238 180 S3 9 1
METFORMIN HCL ER 235 184 10 44
SERTRALINE HCL 215 201 11 26
METOPROLOL SUCCINATE 192 148 12 21
GABAPENTIN 190 139 13 11
DONEPEZIL HCL 186 183 14 32
LOSARTAN POTASSIUM 167 149 15 25
METFORMIN HCL 155 103 16 8
CARVEDILOL 149 135 17 15
MELOXICAM 148 111 18 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 146 106 19 20
TRAMADOL HCL 144 120 20 13
ZOLPIDEM TARTRATE 137 112 21 16
WARFARIN SODIUM 132 129 22 22
TRIAMTERENE-HCTZ 122 110 23 48
ALENDRONATE SODIUM 121 86 24 57
AMITRIPTYLINE HCL 117 80 R 25 45
ATORVASTATIN CALCIUM 112 102 26 18
POLYETHYLENE GLYCOL 3350 99 72 27 69
ATENOLOL 97 97 28 24
LOSARTAN-HYDROCHLOROTHIAZIDE 95 70 29 38
FLUTICASONE PROPIONATE 95 63 29 40
RANITIDINE HCL 93 81 31 37
TAMSULOSIN HCL 89 60 32 33
CLOPIDOGREL 88 75 33 35
ALLOPURINOL 88 71 33 31
FLUOXETINE HCL 86 39 35 51
CIPROFLOXACIN HCL 82 72 36 46
NEXIUM 79 70 37 23
PREDNISONE 79 49 37 42
POTASSIUM CHLORIDE 78 73 39 10
GLIMEPIRIDE 71 48 40 34
QUETIAPINE FUMARATE 69 53 41 75
NAMENDA 68 67 42 43
AZITHROMYCIN 67 51 43 36
ISOSORBIDE MONONITRATE ER 66 66 44 71
NABUMETONE 62 29 45 169
INDAPAMIDE 61 48 46 164
CYMBALTA 60 27 47 53
SPIRIVA 59 28 48 64
CRESTOR 59 55 48 30
BENAZEPRIL HCL 58 53 50 61
LANTUS 57 50 51 68
PANTOPRAZOLE SODIUM 57 35 51 28
LANTUS SOLOSTAR 55 46 53 120
VENTOLIN HFA 54 26 54 83
AMLODIPINE BESYLATE-BENAZEPRIL 53 41 55 59
PAROXETINE HCL 51 51 56 63
DIGOXIN 51 51 56 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.